← The Wire
VKTXNasdaq
Viking Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1607678
Develops drug candidates for unmet medical needs through clinical trials
$3.34B
Market cap
$39.54
Last close
+3.9%
1D
+22.1%
5D
2.9M
Volume
Price · last 39 sessions+24.5%
May 4L $27.75 · H $39.54Jun 29
226
Total filings
May 26, 2026
Last filing
12/31
Fiscal year end
10-Q10-QApr 30, 202610-Q10-QOct 23, 202510-Q10-QJul 23, 202510-Q10-QApr 24, 202510-Q10-QOct 23, 202410-Q10-QJul 24, 202410-Q10-QApr 25, 202410-Q10-QOct 25, 202310-Q10-QJul 26, 202310-Q10-QApr 26, 202310-Q10-QOct 26, 202210-Q10-QJul 27, 202210-Q10-QApr 27, 202210-Q10-QNov 3, 202110-Q10-QJul 28, 202110-Q10-QApr 28, 202110-Q10-QOct 28, 202010-Q10-QJul 29, 202010-Q10-QApr 30, 202010-Q10-QNov 5, 201910-Q10-QAug 1, 201910-Q10-QMay 2, 201910-Q10-QNov 7, 201810-Q10-QAug 9, 201810-Q10-QMay 9, 201810-Q10-QNov 8, 201710-Q10-QAug 9, 201710-Q10-QMay 10, 201710-Q10-QNov 10, 201610-Q10-QAug 11, 201610-Q10-QMay 10, 201610-Q10-QNov 5, 201510-QFORM 10-QAug 14, 201510-QFORM 10-QJun 12, 2015
Insider Activity
In the 90 days to Mar 10, 2026: 1 insider bought $150K · 4 sold $12.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Aubuchon Neil WilliamChief Commercial Officer | Buy | 4,475 | $33.50 | $150K |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 132,454 | $32.29 | $4.3M |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 53,279 | $33.38 | $1.8M |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 41,276 | $34.22 | $1.4M |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 31,961 | $32.30 | $1.0M |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 31,961 | $32.29 | $1.0M |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 13,900 | $33.38 | $464K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 13,600 | $33.37 | $454K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 10,500 | $34.22 | $359K |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 10,300 | $34.24 | $353K |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sell | 6,400 | $35.07 | $224K |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sell | 1,600 | $35.07 | $56K |
| Jan 5, 2026 | Zante GregChief Financial Officer | Sell | 1,500 | $32.09 | $48K |
| Jan 2, 2026 | Foehr Matthew WDirector | Sell | 16,000 | $35.11 | $562K |
| Oct 28, 2025 | Lian BrianPresident & CEO | Sell | 38,989 | $35.01 | $1.4M |
| Oct 28, 2025 | Mancini MariannaChief Operating Officer | Sell | 6,185 | $35.00 | $216K |
| Oct 28, 2025 | Zante GregChief Financial Officer | Sell | 6,185 | $35.00 | $216K |
| Oct 27, 2025 | Rowland Charles A JrDirector | Sell | 60,000 | $35.57 | $2.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance